Cargando…

Optimal preparation of SARS-CoV-2 viral transport medium for culture

INTRODUCTION: The sudden arrival of the COVID-19 pandemic placed significant stresses on supply chains including viral transport medium (VTM). The VTM that was urgently required needed to support viral replication, as well as other routine diagnostic approaches. We describe the preparation and valid...

Descripción completa

Detalles Bibliográficos
Autores principales: McAuley, Julie, Fraser, Claire, Paraskeva, Elena, Trajcevska, Elizabeth, Sait, Michelle, Wang, Nancy, Bert, Eric, Purcell, Damian, Strugnell, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944464/
https://www.ncbi.nlm.nih.gov/pubmed/33691737
http://dx.doi.org/10.1186/s12985-021-01525-z
_version_ 1783662682173341696
author McAuley, Julie
Fraser, Claire
Paraskeva, Elena
Trajcevska, Elizabeth
Sait, Michelle
Wang, Nancy
Bert, Eric
Purcell, Damian
Strugnell, Richard
author_facet McAuley, Julie
Fraser, Claire
Paraskeva, Elena
Trajcevska, Elizabeth
Sait, Michelle
Wang, Nancy
Bert, Eric
Purcell, Damian
Strugnell, Richard
author_sort McAuley, Julie
collection PubMed
description INTRODUCTION: The sudden arrival of the COVID-19 pandemic placed significant stresses on supply chains including viral transport medium (VTM). The VTM that was urgently required needed to support viral replication, as well as other routine diagnostic approaches. We describe the preparation and validation testing of VTM for rapidly expanding diagnostic testing, where the capacity of the VTM to preserve viral integrity, for culture, isolation and full sequence analysis, was maintained. METHODS: VTM was prepared using different methods of sterilization then ‘spiked’ with virus. The VTM was investigated using viral culture in Vero cells, and for nucleic acid detection by quantitative PCR. RESULTS: The best results were obtained by filter and autoclave-based sterilization. The VTM proved robust for culture-based analyses provided the inoculated VTM was stored at 4 °C, and tested within 48 h. The filtered VTM also supported PCR-based diagnosis for at least 5 days when the mock inoculated VTM was held at room temperature. DISCUSSION: The manual handling of VTM production, including filling and sterilization, was optimized. SARS-CoV-2 was spiked into VTM to assess different sterilization methods and measure the effects of storage time and temperature upon VTM performance. While most diagnostic protocols will not require replication competent virus, the use of high quality VTM will allow for the next phase of laboratory analysis in the COVID-19 pandemic, including drug and antibody susceptibility analysis of re-isolated SARS-CoV-2, and for the testing of vaccine escape mutants.
format Online
Article
Text
id pubmed-7944464
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79444642021-03-10 Optimal preparation of SARS-CoV-2 viral transport medium for culture McAuley, Julie Fraser, Claire Paraskeva, Elena Trajcevska, Elizabeth Sait, Michelle Wang, Nancy Bert, Eric Purcell, Damian Strugnell, Richard Virol J Short Report INTRODUCTION: The sudden arrival of the COVID-19 pandemic placed significant stresses on supply chains including viral transport medium (VTM). The VTM that was urgently required needed to support viral replication, as well as other routine diagnostic approaches. We describe the preparation and validation testing of VTM for rapidly expanding diagnostic testing, where the capacity of the VTM to preserve viral integrity, for culture, isolation and full sequence analysis, was maintained. METHODS: VTM was prepared using different methods of sterilization then ‘spiked’ with virus. The VTM was investigated using viral culture in Vero cells, and for nucleic acid detection by quantitative PCR. RESULTS: The best results were obtained by filter and autoclave-based sterilization. The VTM proved robust for culture-based analyses provided the inoculated VTM was stored at 4 °C, and tested within 48 h. The filtered VTM also supported PCR-based diagnosis for at least 5 days when the mock inoculated VTM was held at room temperature. DISCUSSION: The manual handling of VTM production, including filling and sterilization, was optimized. SARS-CoV-2 was spiked into VTM to assess different sterilization methods and measure the effects of storage time and temperature upon VTM performance. While most diagnostic protocols will not require replication competent virus, the use of high quality VTM will allow for the next phase of laboratory analysis in the COVID-19 pandemic, including drug and antibody susceptibility analysis of re-isolated SARS-CoV-2, and for the testing of vaccine escape mutants. BioMed Central 2021-03-10 /pmc/articles/PMC7944464/ /pubmed/33691737 http://dx.doi.org/10.1186/s12985-021-01525-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Short Report
McAuley, Julie
Fraser, Claire
Paraskeva, Elena
Trajcevska, Elizabeth
Sait, Michelle
Wang, Nancy
Bert, Eric
Purcell, Damian
Strugnell, Richard
Optimal preparation of SARS-CoV-2 viral transport medium for culture
title Optimal preparation of SARS-CoV-2 viral transport medium for culture
title_full Optimal preparation of SARS-CoV-2 viral transport medium for culture
title_fullStr Optimal preparation of SARS-CoV-2 viral transport medium for culture
title_full_unstemmed Optimal preparation of SARS-CoV-2 viral transport medium for culture
title_short Optimal preparation of SARS-CoV-2 viral transport medium for culture
title_sort optimal preparation of sars-cov-2 viral transport medium for culture
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944464/
https://www.ncbi.nlm.nih.gov/pubmed/33691737
http://dx.doi.org/10.1186/s12985-021-01525-z
work_keys_str_mv AT mcauleyjulie optimalpreparationofsarscov2viraltransportmediumforculture
AT fraserclaire optimalpreparationofsarscov2viraltransportmediumforculture
AT paraskevaelena optimalpreparationofsarscov2viraltransportmediumforculture
AT trajcevskaelizabeth optimalpreparationofsarscov2viraltransportmediumforculture
AT saitmichelle optimalpreparationofsarscov2viraltransportmediumforculture
AT wangnancy optimalpreparationofsarscov2viraltransportmediumforculture
AT berteric optimalpreparationofsarscov2viraltransportmediumforculture
AT purcelldamian optimalpreparationofsarscov2viraltransportmediumforculture
AT strugnellrichard optimalpreparationofsarscov2viraltransportmediumforculture